Paramus, NJ – August 15, 2012 – WG Critical Care (WGCC) announced today that it will launch Piperacillin and Tazobactam for Injection, the generic form of Zosyn®, in 2.25 g, 3.375 g, 4.5 g and 40.5 g vials. WGCC will begin shipping on August in August. According to IMS Health, the Piperacillin and Tazobactam for Injection market for the twelve months ended March 2012 was $487 million.
About WG Critical Care
WG Critical Care is a fully integrated injectable pharmaceutical company headquartered in Paramus, NJ. Our focus is to provide the hospital and specialty markets with a reliable supply of critical care products. We have a proven 30-year track record of supply of API and finished product to the US market, and a focus on developing new products to address the needs of the market. WG Critical Care provides vertically integrated sourcing, outsourcing, regulatory support, new product development, marketing and sales, enabling us to handle each product from concept to final dose and offer industry-leading quality.
WGCC Media Contact:
Kara Eiseman
847-549-3202
keiseman@wgccrx.com
For more information, please use our Contact Form, or call customer service at 1.888.493.0861.
To order WGCC products, please contact your wholesaler, or call Customer Service at 1.888.493.0861.